Ratios in Focus: Analyzing Amneal Pharmaceuticals Inc (AMRX)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

In the latest session, Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed at $6.12 up 1.16% from its previous closing price of $6.05. In other words, the price has increased by $1.16 from its previous closing price. On the day, 1.25 million shares were traded. AMRX stock price reached its highest trading level at $6.19 during the session, while it also had its lowest trading level at $5.995.

Ratios:

For a deeper understanding of Amneal Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.85. For the most recent quarter (mrq), Quick Ratio is recorded 0.94 and its Current Ratio is at 1.63. In the meantime, Its Debt-to-Equity ratio is 139.06 whereas as Long-Term Debt/Eq ratio is at 127.55.

On March 08, 2021, Goldman Upgraded its rating to Buy which previously was Sell and also upped its target price recommendation from $4 to $6.50.

Guggenheim Upgraded its Neutral to Buy on December 14, 2020, while the target price for the stock was maintained at $5.50.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 11 ’23 when BOYER ANDREW S sold 29,302 shares for $4.13 per share. The transaction valued at 120,921 led to the insider holds 244,739 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 1888350336 and an Enterprise Value of 4577186304. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.79 while its Price-to-Book (P/B) ratio in mrq is 94.85. Its current Enterprise Value per Revenue stands at 1.912 whereas that against EBITDA is 9.14.

Stock Price History:

Over the past 52 weeks, AMRX has reached a high of $6.46, while it has fallen to a 52-week low of $1.74. The 50-Day Moving Average of the stock is 7.06%, while the 200-Day Moving Average is calculated to be 27.64%.

Shares Statistics:

For the past three months, AMRX has traded an average of 1.57M shares per day and 1706210 over the past ten days. A total of 306.56M shares are outstanding, with a floating share count of 102.52M. Insiders hold about 66.77% of the company’s shares, while institutions hold 24.82% stake in the company. Shares short for AMRX as of 1713139200 were 2804272 with a Short Ratio of 1.79, compared to 1710460800 on 2068979. Therefore, it implies a Short% of Shares Outstanding of 2804272 and a Short% of Float of 1.09.

Most Popular

[the_ad id="945"]